In a “shrinkflation” world, investors might want to stop and appreciate the stock market, which is giving them more for less.

The $13 billion figure shows the strength of the company’s railroad, energy and manufacturing, service, and retailing unit.

Doximity stock surges, even after the medical networking and telehealth company’s earnings miss analysts’ targets.

The state’s light regulation and low taxes are luring dozens of big companies. It’s also setting up a water crisis and a ...

Positive readouts in cancer and cardiac drug trials could keep the biotech rally going. Sizing up the stakes for Novartis, ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice. I would like to receive updates and special offers from Dow ...

This is like the best of all worlds for retirees,” says one investment specialist. Thank rising yields on bonds and strong ...

Dave lost 97% of its value before a 1-for-32 reverse split. Now the fintech stock has surged back. As SPACs mount a comeback, ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Nvidia stock has been on a roll ahead of its earnings but AMD's most recent deal could sharpen AI chip competition.

Take-Two reiterates fiscal 2027 guidance for net bookings even as ‘Grand Theft Auto VI’ preorders began June 25.

Replimune secures FDA approval for Tudriqev on its third attempt, making it the company’s first product on the market.